Seto J - Search Results

1

Ng R, Banks GB, Hall JK, Muir LA, Ramos JN, Wicki J, Odom GL, Konieczny P, Seto J, Chamberlain JR, Chamberlain JS. Ng R, et al. Among authors: seto j. Prog Mol Biol Transl Sci. 2012;105:83-111. doi: 10.1016/B978-0-12-394596-9.00004-4. Prog Mol Biol Transl Sci. 2012. PMID: 22137430 Free PMC article. Review.

2

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL. Seto JT, et al. Curr Gene Ther. 2012 Jun;12(3):139-51. doi: 10.2174/156652312800840603. Curr Gene Ther. 2012. PMID: 22533379 Free PMC article. Review.

3

Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

Bengtsson NE, Seto JT, Hall JK, Chamberlain JS, Odom GL. Bengtsson NE, et al. Hum Mol Genet. 2016 Apr 15;25(R1):R9-17. doi: 10.1093/hmg/ddv420. Epub 2015 Oct 8. Hum Mol Genet. 2016. PMID: 26450518 Free PMC article. Review.

4

Therapeutic approaches to muscular dystrophy.

Goyenvalle A, Seto JT, Davies KE, Chamberlain J. Goyenvalle A, et al. Among authors: seto jt. Hum Mol Genet. 2011 Apr 15;20(R1):R69-78. doi: 10.1093/hmg/ddr105. Epub 2011 Mar 24. Hum Mol Genet. 2011. PMID: 21436158 Free PMC article. Review.

5

Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Seto JT, Bengtsson NE, Chamberlain JS. Seto JT, et al. Curr Pediatr Rep. 2014 Jun 1;2(2):102-112. doi: 10.1007/s40124-014-0044-x. Curr Pediatr Rep. 2014. PMID: 24883236 Free PMC article.

6

Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.

Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, Compton AG, Cairns AG, Corbett A, MacArthur DG, Yang N, Reardon K, North KN. Lo HP, et al. Among authors: seto jt. Neuromuscul Disord. 2008 Jan;18(1):34-44. doi: 10.1016/j.nmd.2007.08.009. Epub 2007 Sep 25. Neuromuscul Disord. 2008. PMID: 17897828

7

ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone.

Seto JT, Roeszler KN, Meehan LR, Wood HD, Tiong C, Bek L, Lee SF, Shah M, Quinlan KGR, Gregorevic P, Houweling PJ, North KN. Seto JT, et al. Sci Adv. 2021 Jul 2;7(27):eabg0088. doi: 10.1126/sciadv.abg0088. Print 2021 Jul. Sci Adv. 2021. PMID: 34215586 Free PMC article.

8

NF1 is a critical regulator of muscle development and metabolism.

Sullivan K, El-Hoss J, Quinlan KG, Deo N, Garton F, Seto JT, Gdalevitch M, Turner N, Cooney GJ, Kolanczyk M, North KN, Little DG, Schindeler A. Sullivan K, et al. Among authors: seto jt. Hum Mol Genet. 2014 Mar 1;23(5):1250-9. doi: 10.1093/hmg/ddt515. Epub 2013 Oct 24. Hum Mol Genet. 2014. PMID: 24163128 Free PMC article.

9

The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance.

Garton FC, Houweling PJ, Vukcevic D, Meehan LR, Lee FXZ, Lek M, Roeszler KN, Hogarth MW, Tiong CF, Zannino D, Yang N, Leslie S, Gregorevic P, Head SI, Seto JT, North KN. Garton FC, et al. Among authors: seto jt. Am J Hum Genet. 2018 May 3;102(5):845-857. doi: 10.1016/j.ajhg.2018.03.009. Epub 2018 Apr 26. Am J Hum Genet. 2018. PMID: 29706347 Free PMC article.

10

Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion.

Hogarth MW, Garton FC, Houweling PJ, Tukiainen T, Lek M, Macarthur DG, Seto JT, Quinlan KG, Yang N, Head SI, North KN. Hogarth MW, et al. Among authors: seto jt. Hum Mol Genet. 2016 Mar 1;25(5):866-77. doi: 10.1093/hmg/ddv613. Epub 2015 Dec 17. Hum Mol Genet. 2016. PMID: 26681802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page